Showing results (171-180 of 6,842) with videos related to
Sort By:
Pageof 685
Pharmacoeconomics|July 28, 2016
Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation StudyPei-Jung Lin, Cayla J Saret, Peter J Neumann, et al.Health Affairs (Project Hope)|November 4, 2024
Small-Molecule Drugs Offer Comparable Health Benefits To Biologics At Lower CostsKatherine A Clifford, A Alex Levine, Daniel E Enright, et al.Health Policy (Amsterdam, Netherlands)|March 16, 2010
Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturersJosh J Carlson, Sean D Sullivan, Louis P Garrison, et al.BMC Nephrology|May 1, 2015
Comparative changes in treatment practices and clinical outcomes following implementation of a prospective payment system: the STEPPS studyKeri L Monda, Parveen Nedra Joseph, Peter J Neumann, et al.Applied Health Economics and Health Policy|November 25, 2021
Are Medical Devices Cost-Effective?James D Chambers, Madison C Silver, Flora C Berklein, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 23, 2018
A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical ProceduresJames Chambers, Elle Pope, Kathy Bungay, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 14, 2025
Identifying the Influential Dynamic Inputs in Cost-Effectiveness AnalysesMelanie D Whittington, Joshua T Cohen, Peter J Neumann, et al.The American Journal of Managed Care|October 18, 2019
Variation in US private health plans' coverage of orphan drugsJames D Chambers, Ari D Panzer, David D Kim, et al.Radiology|June 13, 2003
Cost-effectiveness of PET in the diagnosis of Alzheimer diseasePamela M McMahon, Sally S Araki, Eileen A Sandberg, et al.Health Affairs (Project Hope)|November 5, 2019
Little Consistency In Evidence Cited By Commercial Plans For Specialty Drug CoverageJames D Chambers, Ari D Panzer, Elle F Pope, et al.Pageof 685